Faranak Kamangar

Summary

Publications

  1. ncbi request reprint Methotrexate toxicity induced by ciprofloxacin leading to psoriatic plaque ulceration: a case report
    Faranak Kamangar
    515 Spruce St, San Francisco, CA 94118, USA
    Cutis 92:148-50. 2013
  2. doi request reprint Oral vitamin D, still a viable treatment option for psoriasis
    Faranak Kamangar
    Department of Dermatology, University of California, Davis School of Medicine, San Francisco, CA 94118, USA
    J Dermatolog Treat 24:261-7. 2013
  3. pmc How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center
    Faranak Kamangar
    Department of Dermatology, Psoriasis and Skin Treatment Center, University of California, San Francisco, California, USA
    J Dermatolog Treat 24:13-24. 2013
  4. doi request reprint Instant barrier repair: A pilot study investigating occlusion with a new hydrogel patch for the treatment of atopic dermatitis
    Kelly K Park
    Department of Dermatology, University of California San Francisco, Psoriasis and Skin Treatment Center, San Francisco, CA 94118, USA
    J Dermatolog Treat 24:119-21. 2013
  5. doi request reprint Intralesional injections of alefacept may predict systemic response to intramuscular alefacept: results from a pilot study
    Tina Bhutani
    Department of Dermatology, University of California, UCSF Psoriasis and Skin Treatment Center, San Francisco, CA 94118, USA
    J Dermatolog Treat 24:348-50. 2013
  6. doi request reprint An evidence-based review of skin cancer rates on biologic therapies
    Faranak Kamangar
    University of California, Davis School of Medicine, San Francisco Psoriasis Skin and Treatment Center, San Francisco, CA 94118, USA
    J Dermatolog Treat 23:305-15. 2012
  7. doi request reprint Acne in the adult female patient: a practical approach
    Faranak Kamangar
    University of California, San Francisco, CA, USA
    Int J Dermatol 51:1162-74. 2012
  8. ncbi request reprint Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study
    Eric S Lee
    University of California, San Francisco, Department of Dermatology, USA
    J Drugs Dermatol 11:413-4. 2012

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Methotrexate toxicity induced by ciprofloxacin leading to psoriatic plaque ulceration: a case report
    Faranak Kamangar
    515 Spruce St, San Francisco, CA 94118, USA
    Cutis 92:148-50. 2013
    ....
  2. doi request reprint Oral vitamin D, still a viable treatment option for psoriasis
    Faranak Kamangar
    Department of Dermatology, University of California, Davis School of Medicine, San Francisco, CA 94118, USA
    J Dermatolog Treat 24:261-7. 2013
    ..Oral vitamin D is inexpensive and easily available. It is still a viable option and should not be forgotten as a possible treatment for psoriasis...
  3. pmc How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center
    Faranak Kamangar
    Department of Dermatology, Psoriasis and Skin Treatment Center, University of California, San Francisco, California, USA
    J Dermatolog Treat 24:13-24. 2013
    ..Patients with lower income levels had increased cut backs in personal expenses due to co-payments (p = 0.001). Among respondents, the mean annual out-of-pocket expense for a biologic was $557.12 per year, with a range of $0-7000...
  4. doi request reprint Instant barrier repair: A pilot study investigating occlusion with a new hydrogel patch for the treatment of atopic dermatitis
    Kelly K Park
    Department of Dermatology, University of California San Francisco, Psoriasis and Skin Treatment Center, San Francisco, CA 94118, USA
    J Dermatolog Treat 24:119-21. 2013
    ..1% cream twice daily to another lesion. Results after 2-week no treatment follow-up showed hydrogel patch had notable efficacy, and comparable to TAC 0.1% cream. Larger studies are needed to validate these results...
  5. doi request reprint Intralesional injections of alefacept may predict systemic response to intramuscular alefacept: results from a pilot study
    Tina Bhutani
    Department of Dermatology, University of California, UCSF Psoriasis and Skin Treatment Center, San Francisco, CA 94118, USA
    J Dermatolog Treat 24:348-50. 2013
    ....
  6. doi request reprint An evidence-based review of skin cancer rates on biologic therapies
    Faranak Kamangar
    University of California, Davis School of Medicine, San Francisco Psoriasis Skin and Treatment Center, San Francisco, CA 94118, USA
    J Dermatolog Treat 23:305-15. 2012
    ..To critically review the body of clinical trials that report the rates of skin cancer in patients on a biologic therapy, in order to discern whether this therapy is associated with any increase risk of skin cancer...
  7. doi request reprint Acne in the adult female patient: a practical approach
    Faranak Kamangar
    University of California, San Francisco, CA, USA
    Int J Dermatol 51:1162-74. 2012
    ....
  8. ncbi request reprint Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study
    Eric S Lee
    University of California, San Francisco, Department of Dermatology, USA
    J Drugs Dermatol 11:413-4. 2012
    ..The authors report a case of an HIV-infected patient with psoriasis who has remained mostly clear on continuous, uninterrupted etanercept use for over six years...